Suppr超能文献

复发性肛门表皮样癌。

Recurrent epidermoid cancer of the anus.

作者信息

Greenall M J, Magill G B, Quan S H, DeCosse J J

出版信息

Cancer. 1986 Apr 1;57(7):1437-41. doi: 10.1002/1097-0142(19860401)57:7<1437::aid-cncr2820570733>3.0.co;2-t.

Abstract

Of 83 patients with recurrent epidermoid cancer of the anus, 67 had tumors in the anal canal and 16 had tumors at the anal margin. Local pelvic or perineal recurrence after abdominoperineal resection of tumors in the canal had a poor prognosis. Median survival after combination chemotherapy and megavoltage irradiation was 14 months. With irradiation alone, median survival was 7 months, although nearly half of these patients had been treated with orthovoltage techniques. Untreated patients with visceral metastases had a median survival of 8 months, but no improvement in survival was seen after treatment with chemotherapy. In contrast, patients who had metastases in inguinal lymph nodes had a 55% 5-year survival rate after inguinal dissection. Patients with tumors at the anal margin did not have visceral metastases. This is an important difference between tumors arising in the canal and those arising at the anal margin. Local excision was satisfactory treatment for 90% of the patients who had local recurrence in the perianal skin; abdominoperineal resection was rarely required. Inguinal lymph node metastases from margin cancer are uncommon, but three of five such patients survived 5 years after groin dissection. A combination of 5-fluorouracil, mitomycin C, and radiation therapy was used for patients with pelvic recurrence after abdominoperineal resection of epidermoid cancer of the anal canal. In this study, there was no evaluation of the role of megavoltage irradiation alone at the recommended doses of 5500 to 6000 rad for these patients. Some patients with visceral metastases respond to combination chemotherapy, but median survival is not improved; evaluation of new chemotherapeutic regimens is required. Patients with canal tumors metastatic to inguinal nodes should be treated by groin dissection as their prognosis is relatively good. Local recurrence of tumors at the anal margin can be satisfactorily treated by further local excision; those patients with margin tumors metastatic to inguinal nodes require groin dissection.

摘要

在83例复发性肛门表皮样癌患者中,67例肿瘤位于肛管,16例肿瘤位于肛缘。肛管肿瘤经腹会阴切除术后局部盆腔或会阴复发预后较差。联合化疗和兆伏放疗后的中位生存期为14个月。单纯放疗时,中位生存期为7个月,尽管这些患者中有近一半接受了千伏技术治疗。未经治疗的内脏转移患者中位生存期为8个月,但化疗后生存期未见改善。相比之下,腹股沟淋巴结转移患者经腹股沟清扫术后5年生存率为55%。肛缘肿瘤患者无内脏转移。这是肛管肿瘤和肛缘肿瘤之间的一个重要区别。对于90%肛周皮肤局部复发的患者,局部切除是令人满意的治疗方法;很少需要经腹会阴切除术。肛缘癌的腹股沟淋巴结转移并不常见,但5例此类患者中有3例在腹股沟清扫术后存活了5年。对于肛管表皮样癌经腹会阴切除术后盆腔复发的患者,采用5-氟尿嘧啶、丝裂霉素C和放射治疗联合的方法。在本研究中,未评估单独使用推荐剂量5500至6000拉德的兆伏放疗对这些患者的作用。一些内脏转移患者对联合化疗有反应,但中位生存期并未改善;需要评估新的化疗方案。肛管肿瘤转移至腹股沟淋巴结的患者应接受腹股沟清扫术,因为他们的预后相对较好。肛缘肿瘤的局部复发可通过进一步局部切除得到满意治疗;那些肛缘肿瘤转移至腹股沟淋巴结的患者需要进行腹股沟清扫术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验